Aldeyra Therapeutics, Inc. (ALDX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$0
Year ended 2023-12-31
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $0 | -100.0% | 2024-03-07, From 2023-01-01 |
| 2022-12-31 | $16.3K | +109.0% | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $7.8K | n/a | 2023-03-09, From 2021-01-01 |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $9.5K | -96.4% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $263.0K | +962.1% | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | $24.8K | +109.6% | 2019-03-08, From 2017-01-01 |
| 2016-12-31 | $11.8K | -86.3% | 2018-03-29, From 2016-01-02 |
| 2015-12-31 | $86.1K | +512.4% | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | $14.1K | n/a | 2016-03-30, From 2014-01-01 |